In contrast, other studies show that miR-124a overexpression promotes depression-like behaviors, whereas its inhibition yields antidepressant-like effects, potentially via CREB1 and BDNF upregulation (230, 231). This evidence concerns the gene CREB1 and depressive symptom measurement.